微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 37.62% | -1.04% | 2.12% | 24/52 | 36.49% | 百奥赛图 | 74.91% | 行业排名> |
| 2024-12-31 | 36.84% | 5.06% | -0.16% | 28/52 | 35.25% | 百奥赛图 | 74.39% | 行业排名> |
| 2024-09-30 | 36.9% | 9.93% | -2.93% | 29/52 | 35.76% | *ST生物 | 64.96% | 行业排名> |
| 2024-06-30 | 38.02% | 11.83% | 13.43% | 29/52 | 36.65% | 百奥赛图 | 77.67% | 行业排名> |
| 2024-03-31 | 33.52% | -3.57% | -4.43% | 30/52 | 35.74% | *ST生物 | 68.03% | 行业排名> |
| 2023-12-31 | 35.07% | 40.53% | 4.47% | 35/52 | 38.77% | 百奥赛图 | 74.42% | 行业排名> |
| 2023-09-30 | 33.57% | 25.91% | -1.26% | 36/52 | 39.87% | 百诚医药 | 68.19% | 行业排名> |
| 2023-06-30 | 34% | 43.19% | -2.18% | 37/52 | 39.77% | 百奥赛图 | 70.59% | 行业排名> |
| 2023-03-31 | 34.76% | 40.38% | 39.27% | 35/52 | 38.93% | 药康生物 | 69.14% | 行业排名> |
| 2022-12-31 | 24.96% | -22.26% | -6.4% | 47/52 | 40.75% | 药康生物 | 68.49% | 行业排名> |
| 2022-09-30 | 26.66% | -21.24% | 12.3% | 40/52 | 41.1% | 药康生物 | 69.3% | 行业排名> |
| 2022-06-30 | 23.74% | -32.63% | -4.1% | 44/52 | 39.96% | 百奥赛图 | 73.38% | 行业排名> |
| 2022-03-31 | 24.76% | -27.84% | -22.87% | 38/52 | 38.57% | 药康生物 | 73.27% | 行业排名> |
| 2021-12-31 | 32.1% | -6.14% | -5.17% | 42/52 | 42.48% | 药康生物 | 75.32% | 行业排名> |
| 2021-09-30 | 33.85% | 0.48% | -3.95% | 31/52 | 43.07% | 药康生物 | 76.7% | 行业排名> |
| 2021-06-30 | 35.24% | 32.25% | 2.71% | 37/52 | 42.6% | 药康生物 | 74.33% | 行业排名> |
| 2021-03-31 | 34.31% | 118.05% | 0.32% | 24/52 | 39.47% | *ST生物 | 84.53% | 行业排名> |
| 2020-12-31 | 34.2% | -9.23% | 1.52% | 40/52 | 38.51% | *ST生物 | 83.19% | 行业排名> |
| 2020-09-30 | 33.69% | -12.97% | 26.42% | 27/52 | 37.76% | *ST生物 | 83.9% | 行业排名> |
| 2020-06-30 | 26.65% | -29.96% | 69.34% | 33/52 | 39.28% | 成都先导 | 79.36% | 行业排名> |
| 2020-03-31 | 15.74% | -53.5% | -58.24% | 27/52 | 33.2% | 成都先导 | 75.92% | 行业排名> |
| 2019-12-31 | 37.68% | 28.78% | -2.66% | 37/52 | 42.94% | *ST生物 | 78.74% | 行业排名> |
| 2019-09-30 | 38.71% | 45.02% | 1.74% | 19/52 | 44.61% | 成都先导 | 80.82% | 行业排名> |
| 2019-06-30 | 38.04% | 126.85% | 12.42% | 20/52 | 45.09% | 成都先导 | 81.55% | 行业排名> |
| 2019-03-31 | 33.84% | 94.7% | 15.67% | 22/52 | 43.51% | 海特生物 | 84.37% | 行业排名> |
| 2018-12-31 | 29.26% | 61.22% | 9.62% | 42/52 | 42.09% | 海特生物 | 87.74% | 行业排名> |
| 2018-09-30 | 26.69% | 47.83% | 59.15% | 26/52 | 43.61% | 海特生物 | 88.04% | 行业排名> |
| 2018-06-30 | 16.77% | -12.59% | -3.52% | 32/52 | 43.98% | 海特生物 | 92.52% | 行业排名> |
| 2018-03-31 | 17.38% | 10.39% | -4.22% | 26/52 | 45.58% | 海特生物 | 94.18% | 行业排名> |
| 2017-12-31 | 18.15% | -0.69% | 0.51% | 41/52 | 40.94% | 海特生物 | 94.39% | 行业排名> |
| 2017-09-30 | 18.06% | 14.81% | -5.9% | 25/52 | 44.64% | 海特生物 | 94.57% | 行业排名> |
| 2017-06-30 | 19.19% | 15.81% | 21.86% | 29/52 | 43.6% | 退市海医 | 87.54% | 行业排名> |
| 2017-03-31 | 15.75% | -9.83% | -13.83% | 22/52 | 38.7% | 海特生物 | 95.31% | 行业排名> |
| 2016-12-31 | 18.27% | -22.31% | 16.19% | 30/52 | 40.43% | 退市海医 | 91.85% | 行业排名> |
| 2016-09-30 | 15.73% | -53.12% | -5.08% | 19/52 | 37.08% | 海特生物 | 95.45% | 行业排名> |
| 2016-06-30 | 16.57% | -49.41% | -5.12% | 20/52 | 33.77% | 退市海医 | 96.32% | 行业排名> |
| 2016-03-31 | 17.46% | -49.88% | -25.75% | 15/52 | 28.42% | 海特生物 | 95.35% | 行业排名> |